QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $14.45

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 14.45 on March 27, 2026. This significant decline marks a stark contrast to its 52-week high of USD 38.99, reflecting a challenging year for the company, with a staggering 1-year performance drop of 64.06%. The company's market capitalization stands at USD 1,202 million, and it has been grappling with negative financial results for the past 12 consecutive quarters. Key financial metrics indicate a debt-equity ratio of 1.31, suggesting a higher reliance on debt, while the return on equity is reported at -7.95%. Additionally, the stock has not offered any dividend yield, and its price-to-book ratio is notably low at 0.63. QuidelOrtho's performance has consistently lagged behind the S&P 500, with a return of -58.80% over the past year. This underperformance highlights the ongoing difficulties the company faces in a competitive market environment.